KDM2B and its peptides promote the stem cells from apical papilla mediated nerve injury repair in rats by intervening EZH2 function

Yangyang Cao,Yantong Wang,Dengsheng Xia,Zhipeng Fan
DOI: https://doi.org/10.1111/cpr.13756
IF: 8.755
2024-10-03
Cell Proliferation
Abstract:KDM2B promote the neurogenesis of stem cells from apical papilla (SCAP), through up‐regulating mitogen‐activated protein kinase‐1 (MAP2K1), PBX3, Neuregulin‐1 (NRG1), neurofilament heavy (NEFH) and Cadherin‐2 (CDH2) via H3K4me3 methylation. Enhancer of zeste homologue 2 (EZH2) inhibited the neurogenic differentiation in SCAP, and was negatively regulated by KDM2B during neurogenic induction. KDM2B interacted with EZH2, and the binding between KDM2B and EZH2 was decreased during neurogenic induction. KDM2B‐peptides were synthesized basing on KDM2B binding sequences with EZH2. By using KDM2B‐peptides, the binding of EZH2 with KDM2B was effectively decreased. And KDM2B‐peptides promoted the neurogenic differentiation ability of SCAP by intervening EZH2 function. The usage of KDM2B‐peptides treated SCAP improved the motor ability of SCI rats. How to improve the neurogenic potential of mesenchymal stem cells (MSCs) and develop biological agent based on the underlying epigenetic mechanism remains a challenge. Here, we investigated the effect of histone demethylase Lysine (K)‐specific demethylase 2B (KDM2B) on neurogenic differentiation and nerve injury repair by using MSCs from dental apical papilla (SCAP). We found that KDM2B promoted the neurogenic indicators expression and neural spheres formation in SCAP, and modified the Histone H3K4 trimethylation (H3K4me3) methylation on neurogenesis‐related genes. KDM2B improved the SCAP mediated recovery of motor ability at the early healing stage of spinal cord injury rats. Meanwhile, KDM2B acted as a negative regulator to its partner EZH2 during neurogenic differentiation, enhancer of zeste homologue 2 (EZH2) suppressed the neurogenic ability of SCAP. Further, the protein interaction between KDM2B and EZH2 was identified which decreased during neurogenic differentiation. On this basis, we revealed seven key protein binding sequences of KDM2B to EZH2, and synthesized KDM2B‐peptides based on these sequences. By the usage of KDM2B‐peptides, EZH2 function was effectively intervened and the neurogenic ability of SCAP was promoted. More, KDM2B‐peptides significantly improved the SCAP mediated functional recovery at SCI early phase. Our study revealed that KDM2B acted as a promotor to neurogenic differentiation ability of dental MSCs through binding and negatively regulating EZH2, and provided the KDM2B‐peptides as candidate agents for improving the neurogenic ability of MSCs and nerve injury repair.
cell biology
What problem does this paper attempt to address?